July/August 2012, Vol 5, No 5

Page 1

THE PEER-REVIEWED FORUM FOR EVIDENCE IN BENEFIT DESIGN ™ JULY/AUGUST 2012

VOLUME 5, NUMBER 5

FOR PAYERS, PURCHASERS, POLICYMAKERS, AND OTHER HEALTHCARE STAKEHOLDERS

EDITORIAL

“SCOTUS Redux” David B. Nash, MD, MBA COMMENTARY

Healthcare Reform After SCOTUS: Hard Decisions Needed to Avoid Health Sector Meltdown Joseph R. Antos, PhD ™

BUSINESS

Curbing the Costly Trend: Exploring the Need for a Progressive Approach to the Management of Specialty Pharmaceuticals Under the Medical Benefit Michael S. Jacobs, RPh; Kjel A. Johnson, PharmD, BCPS, FCCP, FAMCP Stakeholder Perspective by James T. Kenney, Jr, RPh, MBA CLINICAL

Anticoagulant Use for Prevention of Stroke in a Commercial Population with Atrial Fibrillation Aarti A. Patel, PharmD, MBA; Barb Lennert, RN, BSN, MAOM; Brian Macomson, PharmD; Winnie W. Nelson, PharmD; Gary M. Owens, MD; Samir H. Mody, PharmD, MBA; Jeff Schein, DrPH, MPH Stakeholder Perspective by Jack E. Fincham, PhD, RPh

Conceptual and Analytical Considerations toward the Use of Patient-Reported Outcomes in Personalized Medicine Demissie Alemayehu, PhD; Joseph C. Cappelleri, PhD, MPH Stakeholder Perspective by Michael F. Murphy, MD, PhD INDUSTRY TRENDS

Cost Management through Care Management: A Perspective on Choosing the Right Specialty Pharmacy Partner, PART 1 Michael Einodshofer, RPh, MBA; Stephen Kansler

©2012 Engage Healthcare Communications, LLC www.AHDBonline.com


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.